MoneyWorks4Me

Gland Pharma - Quaterly Results

18 May 2023 Evaluate
A decrease in the sales to Rs. 7854.22 millions was observed for the quarter ended March 2023. The sales stood at Rs. 11030.14 millions during the similar quarter previous year.Net profit of the cmpany stood at Rs. 792.06 millions for the quarter ended March 2023 a decline of -72.30% from Rs. 2859.76 millions  in the same quarter last year.Operating Profit reported a sharp decline to 2080.92 millions from 4136.65 millions in the corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202303 202203 % Var 202303 202203 % Var 202303 202203 % Var
Sales 7854.22 11030.14 -28.79 36165.28 44007.08 -17.82 36165.28 44007.08 -17.82
Other Income 389.39 652.34 -40.31 2404.64 2239.40 7.38 2404.64 2239.40 7.38
PBIDT 2080.92 4136.65 -49.70 12590.13 17345.79 -27.42 12590.13 17345.79 -27.42
Interest 21.81 20.32 7.33 74.14 52.40 41.49 74.14 52.40 41.49
PBDT 1494.50 4116.33 -63.69 11951.38 17293.39 -30.89 11951.38 17293.39 -30.89
Depreciation 375.42 310.75 20.81 1467.36 1102.96 33.04 1467.36 1102.96 33.04
PBT 1119.08 3805.58 -70.59 10484.02 16190.43 -35.25 10484.02 16190.43 -35.25
TAX 327.02 945.82 -65.42 2725.76 4068.88 -33.01 2725.76 4068.88 -33.01
Deferred Tax -104.98 93.23 -212.60 -27.99 140.08 -119.98 -27.99 140.08 -119.98
PAT 792.06 2859.76 -72.30 7758.26 12121.55 -36.00 7758.26 12121.55 -36.00
Equity 164.70 164.30 0.24 164.70 164.30 0.24 164.70 164.30 0.24
PBIDTM(%) 26.49 37.50 -29.35 34.81 39.42 -11.68 34.81 39.42 -11.68
Peers
Company Name CMP
Sun Pharma. Inds. 1861.70
Dr. Reddys Labs. 1216.10
Cipla 1378.15
Lupin 2118.00
Zydus Lifesciences 1170.00
View more..